Clinical Trial Update: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a three-drug regimen of omacetaxine mepesuccinate, cytarabine, and decitabine in older adults with newly diagnosed acute myeloid leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia with
• Acute Myeloid Leukemia with Inv
• Acute Myeloid Leukemia with Maturation
• Acute Myeloid Leukemia with Multilineage Dysplasia Following Myelodysplastic Syndrome
• Megakaryoblastic Leukemia
• Monocytic Leukemia
• Myelomonocytic Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Dacogen (decitabine)
• Synribo (omacetaxine mepesuccinate)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7) | Phase 2 | Status: TERMINATED | Results posted: 2016-05-09